Immediate Impact

2 by Nobel laureates 3 from Science/Nature 59 standout
Sub-graph 1 of 24

Citing Papers

Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
1 intermediate paper

Works of Anne Caldwell being referenced

Blast MRD AML-2: Blockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease (MDR) in Acute Myeloid Leukemia (AML) 2- a Randomized Phase 2 Study of the Venetoclax, Azacitidine, and Pembrolizumab Versus Venetoclax and Azacitidine As First Line Therapy in Older Patients with AML Who Are Ineligible or Who Refuse Intensive Chemotherapy
2020
Immune regulation of canine tumour and macrophage PD‐L1 expression
2016

Author Peers

Author Last Decade Papers Cites
Anne Caldwell 48 18 98 85 82 16 277
Von G. Samedi 92 3 86 103 34 18 312
D. Wilker 51 9 69 86 51 23 330
Fernando Henrique Galvão Tessaro 92 2 90 46 20 15 288
Yali Zhang 110 21 53 78 25 17 324
Qing Liu 88 2 58 124 44 21 317
Yuling Wang 82 2 123 118 23 20 327
Lin Guan 103 6 45 43 44 24 284
Makoto Sugimori 102 1 27 87 26 22 282
Alicia J. Dafferner 77 5 149 87 24 17 315
Hongyan Chen 154 4 50 93 43 22 335

All Works

Loading papers...

Rankless by CCL
2026